Hepatocellular Carcinoma: A Comprehensive Review
Diseases · 02.07.2025 · 13 (7) · 207
DOI: 10.3390/diseases13070207 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 02.07.2025. Verfasst von Nisar Amin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Charleston Area Medical Center, Charleston, WV 25304, USA. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the sixth most common malignancy globally and remains one of the leading causes of cancer-related mortality. Its incidence continues to rise worldwide, and it is currently the fastest-growing cancer by incidence in the United States. HCC most often arises in the context of chronic liver disease, particularly cirrhosis. While chronic viral hepatitis (hepatitis B and C) has traditionally been the primary etiologic factor, recent advances in antiviral therapies and prevention strategies have shifted the epidemiological landscape. Metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease are increasingly prominent risk factors, especially in Western populations. This shift underscores the need for targeted risk factor modification, improved early detection, and enhanced surveillance protocols. The management of HCC necessitates a multidisciplinary approach, incorporating locoregional therapies, surgical resection, liver transplantation, and systemic therapies for advanced-stage disease. Recent advances in systemic treatments, including immune checkpoint inhibitors and combination therapies, have transformed the therapeutic landscape. Despite these developments, significant challenges persist in optimizing treatment, identifying predictive biomarkers, and personalizing therapy. Ongoing research is focused on refining molecular classifications and advancing precision medicine strategies to improve outcomes. This review provides a comprehensive overview of the etiology, surveillance strategies, diagnostic approaches, molecular features, and current treatment modalities for HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Charleston Area Medical Center, Charleston, WV 25304, USA.
- Department of Pathology, Charleston Area Medical Center, Charleston, WV 25304, USA.
- Department of Gastroenterology and Hepatology, Charleston Area Medical Center, Charleston, WV 25304, USA.
Zitieren
APA
Amin, N., Anwar, J., Sulaiman, A., Naumova, N. N., & Anwar, N. (2025). Hepatocellular Carcinoma: A Comprehensive Review. Diseases, 13(7), 207. https://doi.org/10.3390/diseases13070207
Vancouver
Amin N, Anwar J, Sulaiman A, Naumova NN, Anwar N. Hepatocellular Carcinoma: A Comprehensive Review. Diseases. 2025;13(7):207. doi:10.3390/diseases13070207
BibTeX
@article{Amin2025,
author = {Amin, Nisar and Anwar, Javaria and Sulaiman, Abdullahi and Naumova, Nadia Nikolaeva and Anwar, Nadeem},
title = {Hepatocellular Carcinoma: A Comprehensive Review},
journal = {Diseases},
year = {2025},
volume = {13},
number = {7},
pages = {207},
doi = {10.3390/diseases13070207}
}
EUVIMED